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Letter to Editor
Suppurative BCG lymphadenitis in an infant: An uncommon condition
Sir,
Tuberculosis is a major public health issue and a cause of morbidity and mortality in developing countries including India. In the National Immunisation schedule 
(NIS), Bacillus Calmette Guerin (BCG) vaccination is one of the 
important measures to decrease serious forms of TB, including 
miliary or disseminated tuberculosis (TB), especially in pediatric 
population [1,2]. Here, we present the case of suppurative BCG 
lymphadenitis in a 5-months-old infant.
A 5-months-old child presented to the hospital with fever for 
the last 7 days. The patient was given BCG vaccine following 
which a left axillary lymph node was noted. There was no history 
of active pulmonary TB in the patient or a history of contact in 
the family. On examination, lymph node measured approximately 
1.5 × 1.5 cm and was firm, mobile and non-tender. The overlying 
skin was normal. BCG vaccine scar was also noted on the 
ipsilateral side (left upper arm). The patient had no history of 
TB or contact with TB in the past. Systemic examination did not 
reveal any abnormality.
Fine needle aspiration cytology (FNAC) from the left axillary 
lymph node yielded pus and smears were subsequently stained 
with Papanicolaou and Giemsa stains. Smears showed extensive 
necrosis containing many scattered neutrophils, lymphocytes, 
nuclear debris and few degenerating histiocytes (Figure: A-B, 
Pap-200X, and C- Giemsa-200X). Ziehl-Neelsen (ZN) stain for 
acid-fast bacilli (AFB) was positive (AFB-+ve) (Fig. 1C- inset). 
In view of the history of BCG vaccination, the presence of 
suppurative lymphadenitis, vaccinial scar in the ipsilateral arm, 
the aforesaid cytomorphological features were consistent with 
BCG adenitis. The patient was given antibiotics and kept under 
follow-up for any further complications.
BCG vaccination was first included in the World Health 
Organisation’s “Expanded Programme on Immunisation” in 
1974. It is a safe vaccine as it has a very low incidence of serious 
side effects [1-6].
BCG vaccine is recommended to be given along with oral 
polio vaccine (OPV) at first contact of a newborn. It is useful for 
the prevention of serious forms of TB like tubercular meningitis 
and disseminated TB. Following the intradermal injection at the 
insertion of the deltoid, the live attenuated strain of BCG gets 
disseminated to various organs including lymph nodes and may 
cause asymptomatic lymphadenopathy; usually of no clinical 
significance and does not require intervention [3-6]. Usual sites 
of lymph node enlargement are cervical and axillary groups 
of lymph nodes on the ipsilateral side of BCG scar and in the 
supraclavicular lymph node. 
Usually there are no side effects of BCG vaccination; however, 
at times few complications may occur.BCG lymphadenitis 
is one such unusual complication [3-5]. Two types of BCG-
lymphadenitis are usually seen, simple and suppurative; maybe 
necrotizing and associated with epithelioid cell granuloma. The 
diagnosis of BCG adenitis can be confirmed by biopsy followed 
by culture or Gene XPERT [2-6].
Treatment is usually not required in patients with simple 
lymphadenitis and it resolves within a few weeks with only 
antibiotics. However, the patients should be further monitored 
for any complications [3-6]. Suppurative lymphadenitis is 
characterized by the appearance of erythema and other signs 
of inflammation over the skin overlying lymph nodes. The 
treatment of BCG adenitis has been controversial. However, in 
cases where the size of the lymph node is more than 1.5cms and 
there is tenderness, fluctuation, signs of inflammation or sinus 
formation, antitubercular drugs are given [2-6]. If no treatment is 
provided, the suppuration will cause caseous discharge. Systemic 
complications like soft tissue granulomas, osteomyelitis, and 
disseminated disease are extremely rare. 
The risk factors for suppurative lymphadenitis are the 
immunocompromised recipient, reactogenic strain and 
inadvertent injection of a large dose or subcutaneous injection of 
the vaccine. The children with suppurative lymphadenitis should 
Figure 1 A-C: A-C- Smears showing extensive necrosis containing many scattered neutrophils, lymphocytes, nuclear debris and few 
degenerating histiocytes [A&B: Pap-100X; C: Giemsa-200X]. ZN stain showing acid-fast bacilli (AFB-+ve) [Inset, Figure C].
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be screened for any underlying immunodeficiency disorders; 
as children with AIDS or congenital immunodeficiency, 
conditions are predisposed for systemic complications of BCG 
vaccination [4-6].
Awareness of this clinical condition is important, especially 
in rural areas and in mass camps, for early diagnosis and 
management of BCG lymphadenitis. In all such cases, pulmonary 
TB should be ruled out. Other differential diagnoses should 
also be kept in mind like any infective lymphadenitis, parasitic 
infestation, etc before making this diagnosis. FNAC is a simple 
investigative modality for revealing this underlying complication 
of BCG vaccination.
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